Promising antidiabetic drugs, medicinal plants and herbs: An update

International Journal of Pharmacology

Volumn 13, Issue 7, 2017, Pages 732-745

  Yatoo, Mohd Iqbal ^a   Saxena, Archana ^b   Gopalakrishnan, Arumugam ^c   Alagawany, Mahmoud ^d   Dhama, Kuldeep ^c  

^a SHER E KASHMIR UNIVERSITY OF AGRICULTURAL SCIENCES AND TECHNOLOGY OF KASHMIR   (India)

^b CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

^c INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^d Zagazig University   (Egypt)

Author keywords

Antidiabetic; Drugs; Medicinal plants

Indexed keywords

ACARBOSE; ALBIGLUTIDE; ANTIDIABETIC AGENT; ANTIOBESITY AGENT; BILE ACID SEQUESTRANT; COLOCYNTH EXTRACT; DIPEPTIDYL PEPTIDASE IV; DULAGLUTIDE; EXENDIN 4; FENUGREEK EXTRACT; FICUS BENGALENSIS EXTRACT; GLITAZONE DERIVATIVE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GYMNEMA SYLVESTRE EXTRACT; INCRETIN; INSULIN; LIRAGLUTIDE; LORCASERIN; METFORMIN; MIGLITOL; MOMORDICA CHARANTIA EXTRACT; ORAL ANTIDIABETIC AGENT; PHENTERMINE PLUS TOPIRAMATE; PLANT MEDICINAL PRODUCT; POLYPHENOL; RECOMBINANT HUMAN INSULIN; SODIUM GLUCOSE COTRANSPORTER 2; UNINDEXED DRUG;

ANTIDIABETIC ACTIVITY; ARALIACEAE; ASTERACEAE; CLINICAL TRIAL (TOPIC); COLOCYNTH; CUCURBITACEAE; DRUG COST; DRUG EFFICACY; DRUG RELEASE; DRUG SAFETY; DRUG TARGETING; FENUGREEK; FICUS BENGHALENSIS; GYMNEMA SYLVESTRE; HERB; HUMAN; INSULIN RELEASE; LAMIACEAE; LEGUME; LILIACEAE; MEDICINAL PLANT; MOMORDICA CHARANTIA; MORACEAE; NONHUMAN; PHYTOCHEMISTRY; REVIEW; ROSACEAE;

EID: 85026490954     PISSN: 18117775     EISSN: 18125700     Source Type: Journal    
DOI: 10.3923/ijp.2017.732.745     Document Type: Review

References (171)

1. WHO., 2016. Global Report on Diabetes. WHO Press, Geneva, Switzerland, ISBN: 9789241565257, Pages: 86.
2. Unnikrishnan, R., R.M. Anjana and V. Mohan, 2016. Diabetes mellitus and its complications in India. Nat. Rev. Endocrinol., 12: 357-370.
3. Graves, D.T. and R.A. Kayal, 2008. Diabetic complications and dysregulated innate immunity. Front. Biosci., 13: 1227-1239.
4. Wild, S., G. Roglic, A. Green, R. Sicree and H. King, 2004. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 27: 1047-1053.
5. Eleazu, C.O., K.C. Eleazu and M.A. Iroaganachi, 2016. Effect of cocoyam (Colocasia esculenta), unripe plantain (Musa paradisiaca) or their combination on glycated hemoglobin, lipogenic enzymes and lipid metabolism of streptozotocin-induced diabetic rats. Pharm. Biol., 54: 91-97.
6. Kaveeshwar, S.A. and J. Cornwall, 2014. The current state of diabetes mellitus in India. Aust. Med. J., 7: 45-48.
7. Whiting, D.R., L. Guariguata, C. Weil and J. Shaw, 2011. IDF diabetes atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res. Clin. Pract., 94: 311-321.
8. Gwatidzo, S.D. and J.S. Williams, 2017. Diabetes mellitus medication use and catastrophic healthcare expenditure among adults aged 50+ years in China and India: Results from the WHO study on global AGEing and adult health (SAGE). BMC Geriatrics, Vol. 17. 10.1186/s12877-016-0408-x
9. Calcutt, N.A., M.E. Cooper, T.S. Kern and A.M. Schmidt, 2009. Therapies for hyperglycaemia-induced diabetic complications: From animal models to clinical trials. Nature Rev. Drug Discovery, 8: 417-430.
10. Buckingham, B., R.W. Beck, K.J. Ruedy, P. Cheng and C. Kollman et al., 2013. Effectiveness of early intensive therapy on β-cell preservation in type 1 diabetes. Diabetes Care, 36: 4030-4035.
11. Yatoo, M.I., 2015. Evaluation and validation of diabetic biomarkers in small ruminants and biomodulatory management of diabetes mellitus. Ph.D. Thesis, Indian Veterinary Research Institute, Izzatnagar Bareilly, U.P. India.
12. Pandey, A., P. Tripathi, R. Pandey, R. Srivatava and S. Goswami, 2011. Alternative therapies useful in the management of diabetes: A systematic review. J. Pharm. Bioallied. Sci., 3: 504-512.
13. Sun, J. and N.J. Buys, 2016. Glucose-and glycaemic factor-lowering effects of probiotics on diabetes: A meta-analysis of randomised placebo-controlled trials. Br. J. Nutr., 115: 1167-1177.
14. Halimi, S., A. Schweizer, B. Minic, J. Foley and S. Dejager, 2008. Combination treatment in the management of type 2 diabetes: Focus on vildagliptin and metformin as a single tablet. Vascular Health Risk Manage., 4: 481-492.
15. Kalra, S., J.J. Jacob and Y. Gupta, 2016. Newer antidiabetic drugs and calorie restriction mimicry. Indian J. Endocrinol. Metab., 20: 142-146.
16. Sarayani, A., A. Rashidian and K. Gholami, 2014. Low utilisation of diabetes medicines in Iran, despite their affordability (2000-2012): A time-series and benchmarking study. BMJ Open, Vol. 4. 10.1136/bmjopen-2014-005859
17. Hasan, S.S., A.M. Clavarino, A.A. Mamun and T. Kairuz, 2015. A comparative drug utilisation study of the treatment of diabetes in Malaysia and Australia. Aust. Med. J., 8: 179-188.
18. Chaudhury, A., C. Duvoor, V.S.R. Dendi, S. Kraleti and A. Chada et al., 2017. Clinical review of antidiabetic drugs: Implications for type 2 diabetes mellitus management. Front. Endocrinol., Vol. 8. 10.3389/fendo.2017.00006
19. Mahima, A. Rahal, R. Deb, S.K. Latheef and H.A. Samad et al., 2012. Immunomodulatory and therapeutic potentials of herbal, traditional/indigenous and ethnoveterinary medicines. Pak. J. Biol. Sci., 15: 754-774.
20. Tiwari, R., S. Chakraborty, K. Dhama, S. Rajagunalan and S.V. Singh, 2013. Antibiotic resistance-an emerging health problem: Causes, worries, challenges and solutions-A review. Int. J. Curr. Res., 5: 1880-1892.
21. Dhama, K.D., S. Sachan, R. Khandia, A. Munjal and H.M. Iqbal et al., 2017. Medicinal and beneficial health applications of Tinospora cordifolia (Guduchi): A miraculous herb countering various diseases/disorders and its immunomodulatory effects. Recent Patents Endocrine Metab. Immune Drug Discov. 10.2174/1872214811666170301105101.
22. Yadav, A.S., G. Kolluri, M. Gopi, K. Karthik, Y.P.S. Malik and K. Dhama, 2016. Exploring alternatives to antibiotics as health promoting agents in poultry-A review. J. Exp. Biol. Agric. Sci., 4: 368-383.
23. Mukherjee, P.K., N.K. Nema, S. Bhadra, D. Mukherjee, F.C. Braga and M.G. Matsabisa, 2014. Immunomodulatory leads from medicinal plants. Indian J. Tradit. Knowl., 13: 235-256.
24. Ganjhu, R.K., P.P. Mudgal, H. Maity, D. Dowarha, S. Devadiga, S. Nag and G. Arunkumar, 2015. Herbal plants and plant preparations as remedial approach for viral diseases. Virus Dis., 26: 225-236.
25. Andrade-Cetto, A. and M. Heinrich, 2005. Mexican plants with hypoglycaemic effect used in the treatment of diabetes. J. Ethnopharmacol., 99: 325-348.
26. Malviya, N., S. Jain and S. Malviya, 2010. Antidiabetic potential of medicinal plants. Acta Pol. Pharm. Drug Res., 67: 113-118.
27. Wais, M., I. Nazish, A. Samad, S. Beg, S. Abusufyan, S.A. Ajaj and M. Aqil, 2012. Herbal drugs for diabetic treatment: An updated review of patents. Recent Pat. Antiinfect. Drug Discov., 7: 53-59.
28. Perera, P.K. and Y. Li, 2012. Functional herbal food ingredients used in type 2 diabetes mellitus. Pharm. Rev., 6: 37-45.
29. Wang, Z., J. Wang and P. Chan, 2013. Treating type 2 diabetes mellitus with traditional Chinese and Indian medicinal herbs. Evidence-Based Complement. Altern. Med. 10.1155/2013/343594
30. Hsu, P.C., Y.T. Tsai, J.N. Lai, C.T. Wu, S.K. Lin and C.Y. Huang, 2014. Integrating traditional Chinese medicine healthcare into diabetes care by reducing the risk of developing kidney failure among type 2 diabetic patients: A population-based case control study. J. Ethnopharmacol., 156: 358-364.
31. Ezuruike, U.F. and J.M. Prieto, 2014. The use of plants in the traditional management of diabetes in Nigeria: Pharmacological and toxicological considerations. J. Ethnopharmacol., 155: 857-924.
32. Tiwari, B.K., D. Kumar, A.B. Abidi and S.I. Rizvi, 2014. Efficacy of composite extract from leaves and fruits of medicinal plants used in traditional diabetic therapy against oxidative stress in alloxan-induced diabetic rats. ISRN Pharmacol. 10.1155/2014/608590
33. Shikov, A.N., O.N. Pozharitskaya, V.G. Makarov, H. Wagner, R. Verpoorte and M. Heinrich, 2014. Medicinal plants of the Russian pharmacopoeia: Their history and applications. J. Ethnopharmacol., 154: 481-536.
34. Surya, S., A.D. Salam, D.V. Tomy, B. Carla, R.A. Kumar and C. Sunil, 2014. Diabetes mellitus and medicinal plants-a review. Asian Pac. J. Trop. Dis., 4: 337-347.
35. Pang, B., Q. Zhou, T.Y. Zhao, L.S. He and J. Guo et al., 2015. Innovative thoughts on treating diabetes from the perspective of traditional Chinese medicine. Evidence-Based Complement. Altern. Med. 10.1155/2015/905432.
36. Shukia, R., S.B. Sharma, D. Puri, K.M. Prabhu and P.S. Murthy, 2000. Medicinal plants for treatment of diabetes. Indian J. Clin. Biochem., 15: 169-177.
37. Yatoo, M.I., A. Saxena, M.H. Malik, M.K. Sharma and U. Dimri, 2014. Nanotechnology based drug delivery at cellular level: A review. J. Anim. Sci. Adv., 4: 705-709.
38. Modak, M., P. Dixit, J. Londhe, S. Ghaskadbi and T.P.A. Devasagayam, 2007. Indian herbs and herbal drugs used for the treatment of diabetes. J. Clin. Biochem. Nutr., 40: 163-173.
39. Mohamed, E.A.H., M.F. Yam, L.F. Ang, A.J. Mohamed and M.Z. Asmawi, 2013. Antidiabetic properties and mechanism of action of Orthosiphon stamineus Benth bioactive sub-fraction in streptozotocin-induced diabetic rats. J. Acupuncture Meridian Stud., 6: 31-40.
40. Tiwari, N., A.K. Thakur, V. Kumar, A. Dey and V. Kumar, 2014. Therapeutic targets for diabetes mellitus: An update. Clin. Pharmacol. Biopharm., Vol. 3.
41. Asante, D.B., E. Effah-Yeboah, P. Barnes, H.A. Abban and E.O. Ameyaw et al., 2016. Antidiabetic effect of young and old ethanolic leaf extracts of Vernonia amygdalina: A comparative study. J. Diabetes Res. 10.1155/2016/8252741
42. Chu, H., N. Tan and C. Peng, 2009. Progress in research on Pedicularis plants. Zhongguo Zhong Yao Za Zhi, 34: 2536-2546.
43. Abdirahman, Y.A., K.K. Juma, M.J. Mukundi, S.M. Gitahi and D.S. Agyirifo et al., 2015. In-vivo antidiabetic activity and safety of the aqueous stem bark extract of Kleinia squarrosa. J. Diabetes Metab., Vol. 6. 10.4172/2155-6156.1000601.
44. Kunyanga, C.N., J.K. Imungi, M. Okoth, C. Momanyi, H.K. Biesalski and V. Vadivel, 2011. Antioxidant and antidiabetic properties of condensed tannins in acetonic extract of selected raw and processed indigenous food ingredients from Kenya. J. Food Sci., 76: C560-C567.
45. Tiong, S.H., C.Y. Looi, H. Hazni, A. Arya and M. Paydar et al., 2013. Antidiabetic and antioxidant properties of alkaloids from Catharanthus roseus (L.) G. Don. Molecules, 18: 9770-9784.
46. Joseph, B. and D. Jini, 2013. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac. J. Trop. Dis., 3: 93-102.
47. Zhao, D.D., N. Yu, X.K. Li, X. Fang and Q.Q. Mu et al., 2014. Antidiabetic and antioxidative effect of Jiang Tang Xiao Ke granule in high-fat diet and low-dose streptozotocin induced diabetic rats. Evidence-Based Complement. Altern. Med. 10.1155/2014/475192.
48. Vaidya, H.B., A.A. Ahmed, R.K. Goyal and S.K. Cheema, 2013. Glycogen phosphorylase-a is a common target for anti-diabetic effect of iridoid and secoiridoid glycosides. J. Pharm. Pharm. Sci., 16: 530-540.
49. Lavle, N., P. Shukla and A. Panchal, 2016. Role of flavonoids and saponins in the treatment of diabetes mellitus. J. Pharm. Sci. Bioscientific Res., 6: 535-541.
50. Caicedo, A., 2013. Paracrine and autocrine interactions in the human islet: More than meets the eye. Seminars Cell Dev. Biol., 24: 11-21.
51. Vetere, A., A. Choudhary, S.M. Burns and B.K. Wagner, 2014. Targeting the pancreatic β-cell to treat diabetes. Nat. Rev. Drug Discovery, 13: 278-289.
52. Shah, R.B., M. Patel, D.M. Maahs and V.N. Shah, 2016. Insulin delivery methods: Past, present and future. J. Pharmaceut. Invest., 6: 1-9.
53. Lepore, M., S. Pampanelli, C. Fanelli, F. Porcellati and L. Bartocci et al., 2000. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes, 49: 2142-2148.
54. Garber, A.J., R. Ligthelm, J.S. Christiansen and A. Liebl, 2007. Premixed insulin treatment for type 2 diabetes: Analogue or human? Diabetes Obesity Metab., 9: 630-639.
55. Yaturu, S., 2013. Insulin therapies: Current and future trends at dawn. World J. Diabetes, 4: 1-7.
56. Cahn, A., R. Miccoli, A. Dardano and S. Del Prato, 2015. New forms of insulin and insulin therapies for the treatment of type 2 diabetes. Lancet Diabetes Endocrinol., 3: 638-652.
57. Shah, V.N., E.G. Moser, A. Blau, M. Dhingra and S.K. Garg, 2013. The future of basal insulin. Diabetes Technol. Ther., 15: 727-732.
58. Rave, K., E. Potocka, A.H. Boss, M. Marino, D. Costello and R. Chen, 2009. Pharmacokinetics and linear exposure of AFRESA™ compared with the subcutaneous injection of regular human insulin. Diabetes Obesity Metab., 11: 715-720.
59. Cavaiola, T.S. and S. Edelman, 2014. Inhaled insulin: A breath of fresh air? A review of inhaled insulin. Clin. Ther., 36: 1275-1289.
60. Rendell, M., 2000. Dietary treatment of diabetes mellitus. N. Eng. J. Med., 342: 1440-1441.
61. Collier, C.A., C.R. Bruce, A.C. Smith, G. Lopaschuk and D.J. Dyck, 2006. Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. Am. J. Physiol. Endocrinol. Metab., 291: E182-E189.
62. Dell'Aglio, D.M., L.J. Perino, Z. Kazzi, J. Abramson, M.D. Schwartz and B.W. Morgan, 2009. Acute metformin overdose: Examining serum pH, lactate level and metformin concentrations in survivors versus nonsurvivors: A systematic review of the literature. Ann. Emergency Med., 54: 818-823.
63. Eurich, D.T., F.A. McAlister, D.F. Blackburn, S.R. Majumdar, R.T. Tsuyuki, J. Varney and J.A. Johnson, 2007. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: Systematic review. Br. Med. J., Vol. 335. 10.1136/bmj.39314.620174.80.
64. Haffner, S.M, S.E. Kahn, B. Zinman, R.R. Holman and G.F. Viberti et al., 2007. Greater reductions in C-reactive protein with rosiglitazone than with glyburide or metformin despite greater weight gain. Diabetologia, Vol. 50.
65. Buse, J.B., J. Rosenstock, G. Sesti, W.E. Schmidt and E. Montanya et al., 2009. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: A 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet, 374: 39-47.
66. Croomand, K.F. and P.L. McCormack, 2009. Liraglutide: A review of its use in type 2 diabetes mellitus. Drugs, 69: 1985-2004.
67. Kim, S.J., C. Nian, D.J. Doudet and C.H. McIntosh, 2008. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice. Diabetes, 57: 1331-1339.
68. Kim, S.J., C. Nian, D.J. Doudet and C.H. McIntosh, 2009. Dipeptidyl peptidase IV inhibition with MK0431 improves islet graft survival in diabetic NOD mice partially via T-cell modulation. Diabetes, 58: 641-651.
69. Rafaeloff, R., G.L. Pittenger, S.W. Barlow, X.F. Qin and B. Yan et al., 1997. Cloning and sequencing of the pancreatic Islet Neogenesis Associated Protein (INGAP) gene and its expression in islet neogenesis in hamsters. J. Clin. Invest., 99: 2100-2109.
70. Ferrannini, E. and A. Solini, 2012. SGLT2 inhibition in diabetes mellitus: Rationale and clinical prospects. Nat. Rev. Endocrinol., 8: 495-502.
71. Miller, R.A., Q. Chu, J. Xie, M. Foretz, B. Viollet and M.J. Birnbaum, 2013. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature, 494: 256-260.
72. Pathak, R. and M.B. Bridgeman, 2010. Dipeptidyl peptidase-4 (DPP-4) inhibitors in the management of diabetes. Pharm. Ther., 35: 509-513.
73. Meier, J.J., A. Bhushan and P.C. Butler, 2006. The potential for stem cell therapy in diabetes. Pediatric Res., 59: 65R-73R.
74. Mo, R., T. Jiang, J. Di, W. Tai and Z. Gu, 2014. Emerging micro-and nanotechnology based synthetic approaches for insulin delivery. Chem. Soc. Rev., 43: 3595-3629.
75. Chan, L., M. Fujimiya and H. Kojima, 2003. In vivo gene therapy for diabetes mellitus. Trends Mol. Med., 9: 430-435.
76. Fisman, E., M. Motro and A. Tenenbaum, 2008. Non-insulin antidiabetic therapy in cardiac patients: Current problems and future prospects. Adv. Cardiol., 45: 154-170.
77. Stein, S.A., E.M. Lamos and S.N. Davis, 2013. A review of the efficacy and safety of oral antidiabetic drugs. Expert Opin. Drug Safety, 12: 153-175.
78. Reaven, G.M., 1988. Dietary therapy for non-insulin-dependent diabetes mellitus. N. Eng. J. Med., 319: 862-864.
79. Sanchez-Zamora, Y.I. and M. Rodriguez-Sosa, 2014. The role of MIF in type 1 and type 2 diabetes mellitus. J. Diabetes Res. 10.1155/2014/804519
80. Tripathi, A.K., P.K. Bhoyar, J.R. Baheti, D.M. Biyani and M. Khalique et al., 2011. Herbal antidiabetics: A review. Int. J. Res. Pharm. Sci., 2: 30-37.
81. Patel, D.K., S.K. Prasad, R. Kumar and S. Hemalatha, 2012. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian. Pac. J. Trop. Biomed., 2: 320-330.
82. Sathya, A. and P. Siddhuraju, 2012. Role of phenolics as antioxidants, biomolecule protectors and as anti-diabetic factors-evaluation on bark and empty pods of Acacia auriculiformis. Asian Pac. J. Trop. Med., 5: 757-765.
83. Asgar, A., 2013. Anti-diabetic potential of phenolic compounds: A review. Int. J. Food Proper., 16: 91-103.
84. Jain, C., A. Singh, P. Kumar and K. Gautam, 2014. Anti-diabetic potential of flavonoids and other crude extracts of stem bark of Mangifera indica Linn: A comparative study. J. Sci. Innovative Res., 3: 21-27.
85. Mohan, S. and L. Nandhakumar, 2014. Role of various flavonoids: Hypotheses on novel approach to treat diabetes. J. Med. Hypotheses Ideas, 8: 1-6.
86. Vinayagam, R. and B. Xu, 2015. Antidiabetic properties of dietary flavonoids: A cellular mechanism review. Nutr. Metabol., Vol. 12. 10.1186/s12986-015-0057-7.
87. Keller, A.C., J. Ma, A. Kavalier, K. He, A.M.B. Brillantes and E.J. Kennelly, 2011. Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro. Phytomedicine, 19: 32-37.
88. Mohammed, S.A., A.G. Yaqub, A.O. Nicholas, W. Arastus, M. Muhammad and S. Abdullahi, 2013. Review on diabetes, synthetic drugs and glycemic effects of medicinal plants. J. Med. Plants Res., 7: 2628-2637.
89. Arvindekar, A., T. More, P.V. Payghan, K. Laddha, N. Ghoshal and A. Arvindekar, 2015. Evaluation of anti-diabetic and alpha glucosidase inhibitory action of anthraquinones from Rheum emodi. Food Function, 6: 2693-2700.
90. Chien, S.C., Y.C. Wu, Z.W. Chen and W.C. Yang, 2015. Naturally occurring anthraquinones: Chemistry and therapeutic potential in autoimmune diabetes. Evidence-Based Complement. Altern. Med. 10.1155/2015/357357.
91. Auwal, M.S., S. Saka, I.A. Mairiga, K.A. Sanda, A. Shuaibu and A. Ibrahim, 2014. Preliminary phytochemical and elemental analysis of aqueous and fractionated pod extracts of Acacia nilotica (Thorn mimosa). Vet. Res. Forum, 5: 95-100.
92. Juarez-Rojop, I.E., C.A. Tovilla-Zarate, D.E. Aguilar-Dominguez, C.E. Lobato-Garcia and J.L. Ble-Castillo et al., 2014. Phytochemical screening and hypoglycemic activity of Carica papaya leaf in streptozotocin-induced diabetic rats. Revista Brasileira Farmacognosia, 24: 341-347.
93. Ramesh, C., V. Gopal and K. Sembulingam, 2006. Acute and subacute toxicity of an antidiabetic Siddha herbal formulation. Indian J. Trad. Knowledge, 5: 459-462.
94. Van Huyssteen, M., P.J. Milne, E.E. Campbell and M. van de Venter, 2011. Antidiabetic and cytotoxicity screening of five medicinal plants used by traditional African health practitioners in the Nelson Mandela Metropole, South Africa. Afr. J. Trad. Complementary Altern. Med., 8: 150-158.
95. Kasali, F.M., J.N. Kadima, P.T. Mpiana and D.S.T. Tshibangu, 2013. Assessment of antidiabetic activity and acute toxicity of leaf extracts from Physalis peruviana L. in guinea-pig. Asian Pac. J. Trop. Biomed., 3: 841-846.
96. Balogun, F.O., N.T. Tshabalala and A.O.T. Ashafa, 2016. Antidiabetic medicinal plants used by the Basotho tribe of eastern Free State: A review. J. Diabetes Res. 10.1155/2016/4602820.
97. Yakubu, M.T., T.O. Sunmonu, F.B. Lewu, A.O. Ashafa, F.J. Olorunniji and M. Eddouks, 2014. Efficacy and safety of medicinal plants used in the management of diabetes mellitus. Evidence-Based Complement. Altern. Med. 10.1155/2014/793035.
98. Sunmonu, T.O. and A.J. Afolayan, 2013. Evaluation of antidiabetic activity and associated toxicity of Artemisia afra aqueous extract in Wistar rats. Evid. Based Complement. Alternat. Med. 10.1155/2013/929074.
99. Sher, H. and M.N. Alyemeni, 2011. Evaluation of anti-diabetic activity and toxic potential of Lycium shawi in animal models. J. Med. Plants Res., 5: 3387-3395.
100. Pandey, K.B. and S.I. Rizvi, 2009. Plant polyphenols as dietary antioxidants in human health and disease. Oxidative Med. Cell. Longevity, 2: 270-278.
101. Tang, D., Q.B. Chen, X.L. Xin and H.A. Aisa, 2017. Anti-diabetic effect of three new norditerpenoid alkaloids in vitro and potential mechanism via PI3K/Akt signaling pathway. Biomed. Pharm., 87: 145-152.
102. Kianbakht, S., F. Nabati and B. Abasi, 2016. Salvia officinalis (Sage) leaf extract as add-on to statin therapy in hypercholesterolemic type 2 diabetic patients: A randomized clinical trial. Int. J. Mol. Cell. Med., 5: 141-148.
103. Eddouks, M., A. Lemhadri, N.A. Zeggwagh and J.B. Michel, 2005. Potent hypoglycaemic activity of the aqueous extract of Chamaemelum nobile in normal and streptozotocin-induced diabetic rats. Diabetes Res. Clin. Pract., 67: 189-195.
104. Hosseini, A., H. Mollazadeh, M.S. Amiri, H.R. Sadeghnia and A. Ghorbani, 2017. Effects of a standardized extract of Rheum turkestanicum Janischew root on diabetic changes in the kidney, liver and heart of streptozotocin-induced diabetic rats. Biomed. Pharm., 86: 605-611.
105. Kazeem, M.I., A.M. Mayaki, B.F. Ogungbe and A.B. Ojekale, 2016. In-vitro studies on Calotropis procera leaf extracts as inhibitors of key enzymes linked to diabetes mellitus. Iran. J. Pharm. Res., 15: 37-44.
106. Azmi, M.B. and S.A. Qureshi, 2016. Rauwolfia serpentina improves altered glucose and lipid homeostasis in fructose-induced type 2 diabetic mice. Pak. J. Pharm. Sci., 29: 1619-1624.
107. Yousaf, S., A. Hussain, S.U. Rehman, M.S. Aslam and Z. Abbas, 2016. Hypoglycemic and hypolipidemic effects of Lactobacillus fermentum, fruit extracts of Syzygium cumini and Momordica charantia on diabetes induced mice. Pak. J. Pharm. Sci., 29: 1535-1540.
108. Jiao, Y., X. Wang, X. Jiang, F. Kong, S. Wang and C. Yan, 2017. Antidiabetic effects of Morus alba fruit polysaccharides on high-fat diet-and streptozotocin-induced type 2 diabetes in rats. J. Ethnopharmacol., 199: 119-127.
109. Irudayaraj, S.S., S. Christudas, S. Antony, V. Duraipandiyan, A.D.N. Abdullah and S. Ignacimuthu, 2017. Protective effects of Ficus carica leaves on glucose and lipids levels, carbohydrate metabolism enzymes and β-cells in type 2 diabetic rats. Pharmaceut. Biol., 55: 1074-1081.
110. Gryn-Rynko, A., G. Bazylak and D. Olszewska-Slonina, 2016. New potential phytotherapeutics obtained from white mulberry (Morus alba L.) leaves. Biomed. Pharm., 84: 628-636.
111. Kurup, S.B. and S. Mini, 2017. Protective potential of Averrhoa bilimbi fruits in ameliorating the hepatic key enzymes in streptozotocin-induced diabetic rats. Biomed. Pharm., 85: 725-732.
112. Mohammed, A., V.A. Gbonjubola, N.A. Koorbanally and M.S. Islam, 2017. Inhibition of key enzymes linked to type 2 diabetes by compounds isolated from Aframomum melegueta fruit. Pharmaceut. Biol., 55: 1010-1016.
113. Zengin, G., A. Uysal, A. Aktumsek, A. Mocan and A. Mollica et al., 2017. Euphorbia denticulata Lam.: A promising source of phyto-pharmaceuticals for the development of novel functional formulations. Biomed. Pharm., 87: 27-36.
114. Krishnasamy, G., K. Muthusamy, D.R. Chellappan and N. Subbiah, 2016. Antidiabetic, antihyperlipidaemic and antioxidant activity of Syzygium densiflorum fruits in streptozotocin and nicotinamide-induced diabetic rats. Pharm. Biol., 54: 1716-1726.
115. Liu, Y., W. Zhang, C. Xu and X. Li, 2016. Biological activities of extracts from loquat (Eriobotrya japonica Lindl.): A review. Int. J. Mol. Sci., Vol. 17. 10.3390/ijms17121983.
116. Liu, L., D. Tang, H. Zhao, X. Xin and H.A. Aisa, 2017. Hypoglycemic effect of the polyphenols rich extract from Rose rugosa Thunb on high fat diet and STZ induced diabetic rats. J. Ethnopharmacol., 200: 174-181.
117. Kooti, W., Z. Hasanzadeh-Noohi, N. Sharafi-Ahvazi, M. Asadi-Samani and D. Ashtary-Larky, 2016. Phytochemistry, pharmacology and therapeutic uses of black seed (Nigella sativa). Chin. J. Nat. Med., 14: 732-745.
118. Wickramaratne, M.N., J.C. Punchihewa and D.B.M. Wickramaratne, 2016. In-vitro alpha amylase inhibitory activity of the leaf extracts of Adenanthera pavonina. BMC Complement. Alter. Med., Vol. 16. 10.1186/s12906-016-1452-y.
119. Raafat, K., M. Wurglics and M. Schubert-Zsilavecz, 2016. Prunella vulgaris L. active components and their hypoglycemic and antinociceptive effects in alloxan-induced diabetic mice. Biomed. Pharmacother., 84: 1008-1018.
120. Ahmed, K.S.Z., S.Z.A. Sidhra, P. Ponmurugan and B.S. Kumar, 2016. Ameliorative potential of Solanum trilobatum leaf extract and fractions on lipid profile and oxidative stress in experimental diabetes. Pak. J. Pharm. Sci., 29: 1571-1578.
121. Habicht, S.D., C. Ludwig, R.Y. Yang and M.B. Krawinkel, 2014. Momordica charantia and type 2 diabetes: From in vitro to human studies. Curr. Diabetes Rev., 10: 48-60.
122. Alamgeer, M.N. Mushtaq, S. Bashir, I. Ullah and S. Karim et al., 2016. Comparative hypoglycemic activity of different fractions of Thymus serpyllum L. in alloxan induced diabetic rabbits. Pak. J. Pharm. Sci., 29: 1483-1488.
123. Souza, N.C., J.M. de Oliveira, M.D.S. Morrone, R.D.O. Albanus and M.D.S.M. Amarante et al., 2016. Turnera subulata anti-inflammatory properties in lipopolysaccharide-stimulated RAW 264.7 macrophages. J. Med. Food, 19: 922-930.
124. Nunthanawanich, P., W. Sompong, S. Sirikwanpong, K. Makynen, S. Adisakwattana, W. Dahlan and S. Ngamukote, 2016. Moringa oleifera aqueous leaf extract inhibits reducing monosaccharide-induced protein glycation and oxidation of bovine serum albumin. SpringerPlus, Vol. 5. 10.1186/s40064-016-2759-3.
125. Mollazadeh, H., H.R. Sadeghnia, A. Hoseini, M. Farzadnia and M.T. Boroushaki, 2016. Effects of pomegranate seed oil on oxidative stress markers, serum biochemical parameters and pathological findings in kidney and heart of streptozotocin-induced diabetic rats. Renal Fail., 38: 1256-1266.
126. Hosseini, S., H.F. Huseini, B. Larijani, K. Mohammad, A. Najmizadeh, K. Nourijelyani and L. Jamshidi, 2014. The hypoglycemic effect of Juglans regia leaves aqueous extract in diabetic patients: A first human trial. DARU J. Pharm. Sci., Vol. 22. 10.1186/2008-2231-22-19.
127. Domekouo, U.L.F., F. Longo, P.A. Tarkang, A.T. Tchinda and N. Tsabang et al., 2016. Evaluation of the antidiabetic and antioxidant properties of Morinda lucida stem bark extract in streptozotocin intoxicated rats. Pak. J. Pharm. Sci., 29: 903-911.
128. Cai, W., L. Yu, Y. Zhang, L. Feng and S. Kong et al., 2016. Extracts of Coreopsis tinctoria Nutt. flower exhibit antidiabetic effects via the inhibition of α-glucosidase activity. J. Diabetes Res. 10.1155/2016/2340276
129. Agwaya, M.S., P.C. Vuzi and A.M. Nandutu, 2016. Hypoglycemic activity of aqueous root bark extract Zanthoxylum chalybeum in alloxan-induced diabetic rats. J. Diabetes Res. 10.1155/2016/8727590.
130. Abou Khalil, N.S., A.S. Abou-Elhamd, S.I. Wasfy, I.M. El Mileegy, M.Y. Hamed and H.M. Ageely, 2016. Antidiabetic and antioxidant impacts of desert date (Balanites aegyptiaca) and Parsley (Petroselinum sativum) aqueous extracts: Lessons from experimental rats. J. Diabetes Res. 10.1155/2016/8408326.
131. Jiang, W., L. Gao, P. Li, H. Kan and J. Qu et al., 2017. Metabonomics study of the therapeutic mechanism of fenugreek galactomannan on diabetic hyperglycemia in rats, by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. J. Chromatogr. B Anal. Technol. Biomed. Life Sci., 1044-1045: 8-16.
132. Ben Hmidene, A., M. Hanaki, K. Murakami, K. Irie, H. Isoda and H. Shigemori, 2017. Inhibitory activities of antioxidant flavonoids from Tamarix gallica on amyloid aggregation related to Alzheimer's and type 2 diabetes diseases. Biol. Pharm. Bull., 40: 238-241.
133. Zhai, X., G.B. Lenon, C.C. Xue and C.G. Li, 2016. Euonymus alatus: A review on its phytochemistry and antidiabetic activity. Evidence-Based Complement. Altern. Med. 10.1155/2016/9425714.
134. Mehrzadi, S., B. Tavakolifar, H.F. Huseini, S.H. Mosavat and M. Heydari, 2016. The efficacy of Boswellia serrata gum resin for control of lipid profile and blood glucose in diabetic patients. Iran. J. Med. Sci., Vol. 41.
135. Yamac, M., M. Zeytinoglu, H. Senturk, K. Kartkaya and G. Kanbak et al., 2016. Effects of black hoof medicinal mushroom, Phellinus linteus (Agaricomycetes), polysaccharide extract in streptozotocin-induced diabetic rats. Int. J. Med. Mushrooms, 18: 301-311.
136. Sheikh, Y., B.C. Maibam, N.C. Talukdar, D.C. Deka and J.C. Borah, 2016. In vitro and in vivo anti-diabetic and hepatoprotective effects of edible pods of Parkia roxburghii and quantification of the active constituent by HPLC-PDA. J. Ethnopharmacol., 191: 21-28.
137. Yan, S., X. Zhang, X. Wen, Q. Lv, C. Xu, C. Sun and X. Li, 2016. Purification of flavonoids from Chinese bayberry (Morella rubra Sieb. et Zucc.) fruit extracts and α-glucosidase inhibitory activities of different fractionations. Molecules, Vol. 21. 10.3390/molecules21091148.
138. Dashtban, M., H. Sarir and A. Omidi, 2016. The effect of Prosopis farcta beans extract on blood biochemical parameters in streptozotocin-induced diabetic male rats. Adv. Biomed. Res., Vol. 5. 10.4103/2277-9175.185575.
139. Agnihotri, A. and V. Singh, 2013. Effect of Tamarindus indica Linn. and Cassia fistula Linn. stem bark extracts on oxidative stress and diabetic conditions. Acta Pol. Pharm., 70: 1011-1019.
140. Taher, M., T.M. Zakaria, D. Susanti and Z.A. Zakaria, 2016. Hypoglycaemic activity of ethanolic extract of Garcinia mangostana Linn. in normoglycaemic and streptozotocin-induced diabetic rats. BMC Complementary Alter. Med., Vol. 16. 10.1186/s12906-016-1118-9.
141. Akhtar, M.T., M.S. Bin Mohd Sarib, I.S. Ismail, F. Abas, A. Ismail, N.H. Lajis and K. Shaari, 2016. Anti-diabetic activity and metabolic changes induced by Andrographis paniculata plant extract in obese diabetic rats. Molecules, Vol. 21. 10.3390/molecules21081026.
142. Satyanarayana, K., K. Sravanthi, I.A. Shaker and R. Ponnulakshmi, 2015. Molecular approach to identify antidiabetic potential of Azadirachta indica. J. Ayurveda Integr. Med., 6: 165-174.
143. Sulyman, A.O., J.O. Akolade, S.A. Sabiu, R.A. Aladodo and H.F. Muritala, 2016. Antidiabetic potentials of ethanolic extract of Aristolochia ringens (Vahl.) roots. J. Ethnopharmacol., 182: 122-128.
144. Khaliq, T., M. Sarfraz and M.A. Ashraf, 2015. Recent progress for the utilization of Curcuma longa, Piper nigrum and Phoenix dactylifera seeds against type 2 diabetes. West Indian Med. J., 64: 527-532.
145. Oguntibeju, O.O., S. Meyer, Y.G. Aboua and M. Goboza, 2016. Hypoxis hemerocallidea si gni fi cantl y reduced hyperglycaemia and hyperglycaemic-induced oxidative stress in the liver and kidney tissues of streptozotocin-induced diabetic male Wistar rats. Evidence-Based Complement. Altern. Med. 10.1155/2016/8934362
146. Mohammed, A., N.A. Koorbanally and M.S. Islam, 2016. Phytochemistry, antioxidative activity and inhibition of key enzymes linked to type 2 diabetes by various parts of Aframomum melegueta in vitro. Acta Pol. Pharm., 73: 403-417.
147. Kalpana, K. and K.V. Pugalendi, 2011. Antioxidative and hypolipidemic efficacy of alcoholic seed extract of Swietenia macrophylla in streptozotocin diabetic rats. J. Basic Clin. Physiol. Pharmacol., 22: 11-21.
148. Khattab, H.A., N.A. El-Shitany, I.Z. Abdallah, F.M. Yousef and H.M. Alkreathy, 2015. Antihyperglycemic potential of Grewia asiatica fruit extract against streptozotocin-induced hyperglycemia in rats: Anti-inflammatory and antioxidant mechanisms. Oxidative Med. Cell. Longevity, Vol. 2015. 10.1155/2015/549743
149. Mahendran, G., G. Thamotharan, S. Sengottuvelu and V.N. Bai, 2014. Anti-diabetic activity of Swertia corymbosa (Griseb.) Wight ex C.B. Clarke aerial parts extract in streptozotocin induced diabetic rats. J. Ethnopharmacol., 151: 1175-1183.
150. Dewanjee, S., A.K. Das, R. Sahu and M. Gangopadhyay, 2009. Antidiabetic activity of Diospyros peregrina fruit: Effect on hyperglycemia, hyperlipidemia and augmented oxidative stress in experimental type 2 diabetes. Food Chem. Toxicol., 47: 2679-2685.
151. D'Souza, J.J., P.P. D'Souza, F. Fazal, A. Kumar, H.P. Bhat and M.S. Baliga, 2014. Anti-diabetic effects of the Indian indigenous fruit Emblica officinalis Gaertn: Active constituents and modes of action. Food Funct., 5: 635-644.
152. Narendhirakannan, R.T. and S. Subramanian, 2010. Biochemical evaluation of the protective effect of Aegle marmelos (L.), Corr. leaf extract on tissue antioxidant defense system and histological changes of pancreatic β-cells in streptozotocin-induced diabetic rats. Drug Chem. Toxicol., 33: 120-130.
153. Taghizadeh, M., A.A. Rashidi, A.A. Taherian, Z. Vakili, M.S. Sajadian and M. Ghardashi, 2016. Antidiabetic and antihyperlipidemic effects of ethanol extract of Rosa canina L. fruit on diabetic rats: An experimental study with histopathological evaluations. J. Evidence-Based Complementary Altern. Med., 21: NP25-NP30.
154. Seida, A., H. El-Hefnawy, D. Abou-Hussein, F.A. Mokhtar and A. Abdel-Naim, 2015. Evaluation of Medicago sativa L. sprouts as antihyperlipidemic and antihyperglycemic agent. Pak. J. Pharm. Sci., 28: 2061-2074.
155. Moradkhani, S., I. Salehi, S. Abdolmaleki and A. Komaki, 2015. Effect of Calendula officinalis hydroalcoholic extract on passive avoidance learning and memory in streptozotocin-induced diabetic rats. Ancient Sci. Life, 34: 156-161.
156. Han, J.M., M.H. Kim, Y.Y. Choi, H. Lee, J. Hong and W.M. Yang, 2015. Effects of Lonicera japonica Thunb. on type 2 diabetes via PPAR Ү activation in rats. Phytotherapy Res., 29: 1616-1621.
157. Ali, M.A., M.I.I. Wahed, N.A. Khatune, B.M. Rahman, R.K. Barman and M.R. Islam, 2015. Antidiabetic and antioxidant activities of ethanolic extract of Semecarpus anacardium (Linn.) bark. BMC Complement. Alter. Med., Vol. 15. 10.1186/s12906-015-0662-z
158. Hu, X., D. Cheng, L. Wang, S. Li and Y. Wang et al., 2015. Evaluation of anti-hyperglycemic effect of Actinidia kolomikta (Maxim. et Rur.) Maxim. root extract. Pak. J. Pharm. Sci., 28: 1135-1140.
159. Akash, M.S.H., K. Rehman and S. Chen, 2014. Spice plant Allium cepa: Dietary supplement for treatment of type 2 diabetes mellitus. Nutrition, 30: 1128-1137.
160. Sharma, N. and V. Garg, 2009. Antidiabetic and antioxidant potential of ethanolic extract of Butea monosperma leaves in alloxan-induced diabetic mice. Indian J. Biochem. Biophys., 46: 99-105.
161. Ilkhanizadeh, B., A. Shirpoor, S. Nemati and Y. Rasmi, 2016. Protective effects of ginger (Zingiber officinale) extract against diabetes-induced heart abnormality in rats. Diabetes Metab. J., 40: 46-53.
162. Farid, O., M. Hebi, M. Ajebli, A.E. Hidani and M. Eddouks, 2017. Antidiabetic effect of Ruta montana L. in streptozotocin-induced diabetic rats. J. Basic Clin. Physiol. Pharmacol. 10.1515/jbcpp-2016-0030
163. Chang, C.L., Y. Lin, A.P. Bartolome, Y.C. Chen, S.C. Chiu and W.C. Yang, 2013. Herbal therapies for type 2 diabetes mellitus: Chemistry, biology and potential application of selected plants and compounds. Evid.-Based Complement. Altern. Med. 10.1155/2013/378657
164. Zhou, K., H.K. Pedersen, A.Y. Dawed and E.R. Pearson, 2016. Pharmacogenomics in diabetes mellitus: Insights into drug action and drug discovery. Nat. Rev. Endocrinol., 12: 337-346.
165. Prabhakar, P.K. and M. Doble, 2008. A target based therapeutic approach towards diabetes mellitus using medicinal plants. Curr. Diabetes Rev., 4: 291-308.
166. Harvey, A.L., 2010. Plant natural products in anti-diabetic drug discovery. Curr. Org. Chem., 14: 1670-1677.
167. Piya, M.K., A.A. Tahrani and A.H. Barnett, 2010. Emerging treatment options for type 2 diabetes. Br. J. Clin. Pharmacol., 70: 631-644.
168. Cheng, S.T.W., L. Chen, S.Y.T. Li, E. Mayoux and P.S. Leung, 2016. The effects of empagliflozin, an SGLT2 inhibitor, on pancreatic β-cell mass and glucose homeostasis in type 1 diabetes. PLoS ONE, Vol. 11. 10.1371/journal.pone.0147391.
169. Rochester, C.D. and O. Akiyode, 2014. Novel and emerging diabetes mellitus drug therapies for the type 2 diabetes patient. World J. Diab., 5: 305-315.
170. DeFronzo, R.A., C.L. Triplitt, M. Abdul-Ghani and E. Cersosimo, 2014. Novel agents for the treatment of type 2 diabetes. Diabetes Spectrum, 27: 100-112.
171. Singab, A.N., F.S. Youssef and M.L. Ashour, 2014. Medicinal plants with potential antidiabetic activity and their assessment. Med. Aromat. Plants, Vol. 3. 10.4172/2167-0412.1000151.